Form4insider filings, from the source

SEC Form 4 · accession 0001181431-15-007002

Clovis Oncology, Inc. · CLVS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
May 14, 2015
Accepted (ET)
May 15, 2015 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2May 14, 2015J1,139,891$0.00D1,139,890ISee Note 2
Common StockF4May 14, 2015J11,399$0.00A11,399ISee Note 4
Common StockF4May 14, 2015J11,399$0.00D0ISee Note 4
Common StockMay 14, 2015J287$0.00A574D
Common StockF8May 14, 2015J287$0.00A574ISee Note 8
Common StockF10May 14, 2015J2,424$0.00A2,424ISee Note 10
Common StockF11,F10May 15, 2015S500$91.864D1,924ISee Note 10
Common StockF12,F10May 15, 2015S1,924$92.5713D0ISee Note 10

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses